These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year
What a year for psychedelics!
Psychedelic Stock Gainers And Losers From December 30, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.50% at $2.66 GH Research (NASDAQ:GHRS) shares closed up 3.23%…
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
Dow Rises 150 Points; Mission Produce Shares Slide
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
Dow Surges Over 100 Points; Crude Oil Rises Sharply
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
ATAI Life Sciences’s Return On Capital Employed Insights
According to Benzinga Pro data, during Q3, ATAI Life Sciences (NASDAQ:ATAI) posted sales of $24 thousand. Earnings were…
atai Life Sciences Initiates Phase 2b proof-of-concept trial Of RL-007 For Cognitive Impairment Associated With Schizophrenia
The phase 2b proof-of-concept trial will evaluate the novel compound, RL-007, for pro-cognitive effects in patients with Cognitive Impairment Associated with Schizophrenia (CIAS).
The trial was initiated and has begun
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
Part one of a three-part series.
The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.
Psychedelic Stock Gainers And Losers From December 9, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.78% at $1.11 Numinus Wellness (OTC:NUMIF) shares closed up 1.88% at…